Literature DB >> 10611072

Progesterone receptor A and B messenger ribonucleic acid levels in the anterior pituitary of rats are regulated by estrogen.

M Szabo1, S M Kilen, S J Nho, N B Schwartz.   

Abstract

In target tissues of most mammalian and avian species, progesterone receptors (PR) are expressed as structurally related, but functionally distinct, isoforms A and B, and they are regulated by estrogen (E) as well as by their cognate ligand, progesterone (P(4)). The objectives of the present work were to identify mRNA expression for the A and B isoforms of PR in the anterior pituitary of the rat, to examine its regulation by gonadal steroids, and to compare this regulation with that in the primary target organ, the uterus. Messenger RNAs for the PR isoforms, determined by two separate reverse transcription-polymerase chain reaction protocols, one that detects PR A and PR B equally and the other specific for PR B, were identified in anterior pituitary of female and male rats. In anterior pituitary of cycling female rats, steady-state mRNA levels for both PR A+B and PR B were highest at 0900 h on proestrus, declined rapidly to nadir values at 0900 h on metestrus (PR A+B) or 0900 h on estrus (PR B), and remained below proestrous values through 2100 h on diestrus. Administration of E to intact proestrous female rats caused significant increases in mRNA for both PR A+B and PR B on estrus and metestrus. Blockade of P(4) action by administration of the antiprogestins RU-486 and ZK-98299 on proestrus had no effect on PR mRNA levels on the morning of estrus. Ovariectomy two and ten days after surgery markedly reduced mRNA levels for both PR A+B and PR B. Whereas treatment of 10-day-ovariectomized rats with E led to marked induction of mRNA for PR A+B and PR B two days later, treatment with P(4) one day after treatment had no effect on basal or E-stimulated PR mRNA. Regulation of PR mRNA expression in the pituitary differed from that in the uterus, in which P(4) treatment of ovariectomized rats antagonized the E-induced rise in mRNA for PR B, and antiprogestins increased mRNA for both isoforms. In addition to induction of PR mRNA in the pituitary of female rats by E in vivo, we also demonstrated induction by E in primary culture of anterior pituitary cells in vitro. We conclude that in the anterior pituitary of female rats, both the A and B isoforms of PR are expressed and regulated by E.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10611072     DOI: 10.1095/biolreprod62.1.95

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  18 in total

Review 1.  Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters.

Authors:  Shaila Mani; Wendy Portillo
Journal:  Front Neuroendocrinol       Date:  2010-01-29       Impact factor: 8.606

Review 2.  Progestin receptor subtypes in the brain: the known and the unknown.

Authors:  Shaila Mani
Journal:  Endocrinology       Date:  2008-02-28       Impact factor: 4.736

3.  Human follicular fluid from superovulated women inhibits progesterone receptor-dependent gonadotropin-releasing hormone self-priming in an estrous cycle-dependent manner in the rat.

Authors:  A Gordon; R Aguilar; J C Garrido-Gracia; C Bellido; Y Millán; S Guil-Luna; J A García-Velasco; E Bellido-Muñoz; J Martín de las Mulas; J E Sánchez-Criado
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

Review 4.  Non-clinical studies of progesterone.

Authors:  R Sitruk-Ware
Journal:  Climacteric       Date:  2018-05-23       Impact factor: 3.005

5.  8-alkylthio-6-thio-substituted theophylline analogues as selective noncompetitive progesterone receptor antagonists.

Authors:  Irene O Aninye; Kenneth C Berg; Andy R Mollo; Steven K Nordeen; Elizabeth M Wilson; David J Shapiro
Journal:  Steroids       Date:  2012-03-06       Impact factor: 2.668

6.  Effects of progesterone synthesized de novo in the developing Purkinje cell on its dendritic growth and synaptogenesis.

Authors:  H Sakamoto; K Ukena; K Tsutsui
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

7.  Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities.

Authors:  Andrea Heinzlmann; Katalin Köves; György M Nagy
Journal:  Endocrine       Date:  2010-03-30       Impact factor: 3.633

8.  Role of estradiol in cortisol-induced reduction of luteinizing hormone pulse frequency.

Authors:  Amy E Oakley; Kellie M Breen; Alan J Tilbrook; Elizabeth R Wagenmaker; Fred J Karsch
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

9.  Effects of progesterone (P) and antiprogestin RU486 on LH and FSH release by incubated pituitaries from rats treated with the SERM LY11701 8-HCl and/or recombinant human FSH.

Authors:  C Bellido; R Aguilar; J C Garrido-Gracia; J E Sánchez-Criado
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

10.  The characteristic change in the distribution of S-100 immunoreactive folliculostellate cells in rat anterior pituitary upon long-term estrogen treatment is prevented by concomitant progesterone treatment.

Authors:  Andrea Heinzlmann; Katalin Köves
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.